Catherine Serke Williams

Array ( [id] => 6002695 [patent_doc_number] => 20110118140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'METHODS FOR IDENTIFICATION, AND COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 13/019142 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 33349 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118140.pdf [firstpage_image] =>[orig_patent_app_number] => 13019142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936007 [patent_doc_number] => 20110212114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'METHOD FOR MAKING TARGETED THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 13/016576 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22935 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212114.pdf [firstpage_image] =>[orig_patent_app_number] => 13016576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101587 [patent_doc_number] => 20110165079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'PEPTIDE FOR TRANSMIGRATION ACROSS BLOOD BRAIN BARRIER AND DELIVERY SYSTEMS COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/979804 [patent_app_country] => US [patent_app_date] => 2010-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5731 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165079.pdf [firstpage_image] =>[orig_patent_app_number] => 12979804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083532 [patent_doc_number] => 20110143993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'ENDOTHELIAL BASEMENT MEMBRANE TARGETING PEPTIDE LIGANDS' [patent_app_type] => utility [patent_app_number] => 12/969345 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20647 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20110143993.pdf [firstpage_image] =>[orig_patent_app_number] => 12969345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968984 [patent_doc_number] => 20110150844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'COMPOSITIONS AND METHODS FOR CONTROLLING PROLIFERATION AND DIFFERENTIATION OF CELLS' [patent_app_type] => utility [patent_app_number] => 12/966612 [patent_app_country] => US [patent_app_date] => 2010-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19920 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150844.pdf [firstpage_image] =>[orig_patent_app_number] => 12966612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6212296 [patent_doc_number] => 20110135596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'FUSION PROTEIN COMPRISING UBIQUITIN OR UBIQUITIN-LIKE PROTEIN, MEMBRANE TRANSLOCATION SEQUENCE AND BIOLOGICALLY ACTIVE MOLECULE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/959965 [patent_app_country] => US [patent_app_date] => 2010-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6683 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20110135596.pdf [firstpage_image] =>[orig_patent_app_number] => 12959965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8533365 [patent_doc_number] => 08309520 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-13 [patent_title] => 'Fully synthetic albumin analog' [patent_app_type] => utility [patent_app_number] => 12/952629 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 6232 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12952629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10148130 [patent_doc_number] => 09180395 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-10 [patent_title] => 'Porous thin films' [patent_app_type] => utility [patent_app_number] => 13/508984 [patent_app_country] => US [patent_app_date] => 2010-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 8210 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8822136 [patent_doc_number] => 20130123181 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'Factor VIII T Cell Epitope Variants Having Reduced Immunogenicity' [patent_app_type] => utility [patent_app_number] => 13/509508 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 40733 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8815137 [patent_doc_number] => 20130116182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'Factor VIII B Cell Epitope Variants Having Reduced Immunogenicity' [patent_app_type] => utility [patent_app_number] => 13/509506 [patent_app_country] => US [patent_app_date] => 2010-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 40737 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936870 [patent_doc_number] => 20110212541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'COMPOSITIONS AND METHODS TO PROTECT CELLS BY BLOCKING ENTRY OF PATHOGEN PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/944345 [patent_app_country] => US [patent_app_date] => 2010-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 28024 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212541.pdf [firstpage_image] =>[orig_patent_app_number] => 12944345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944777 [patent_doc_number] => 20110105397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'METHOD FOR TREATING HEART FAILURE WITH STRESSCOPIN-LIKE PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/940019 [patent_app_country] => US [patent_app_date] => 2010-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 33592 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105397.pdf [firstpage_image] =>[orig_patent_app_number] => 12940019 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6215708 [patent_doc_number] => 20110137406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'BIOACTIVE STENTS FOR TYPE II DIABETICS AND METHODS FOR USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/912440 [patent_app_country] => US [patent_app_date] => 2010-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22570 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20110137406.pdf [firstpage_image] =>[orig_patent_app_number] => 12912440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7540549 [patent_doc_number] => 08058392 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Carbon nanotube binding peptides' [patent_app_type] => utility [patent_app_number] => 12/895946 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10355 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058392.pdf [firstpage_image] =>[orig_patent_app_number] => 12895946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515512 [patent_doc_number] => 08039584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Carbon nanotube binding peptides' [patent_app_type] => utility [patent_app_number] => 12/895904 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10381 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039584.pdf [firstpage_image] =>[orig_patent_app_number] => 12895904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149311 [patent_doc_number] => 20110020906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'CARBON NANOTUBE BINDING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/896041 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10359 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020906.pdf [firstpage_image] =>[orig_patent_app_number] => 12896041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515511 [patent_doc_number] => 08039583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Carbon nanotube binding peptides' [patent_app_type] => utility [patent_app_number] => 12/895899 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10355 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039583.pdf [firstpage_image] =>[orig_patent_app_number] => 12895899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149307 [patent_doc_number] => 20110020902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'CARBON NANOTUBE BINDING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/895933 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10363 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020902.pdf [firstpage_image] =>[orig_patent_app_number] => 12895933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196558 [patent_doc_number] => 20110028316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'CARBON NANOTUBE BINDING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 12/896061 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10356 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028316.pdf [firstpage_image] =>[orig_patent_app_number] => 12896061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550846 [patent_doc_number] => 08063179 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Carbon nanotube binding peptides' [patent_app_type] => utility [patent_app_number] => 12/895921 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10327 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063179.pdf [firstpage_image] =>[orig_patent_app_number] => 12895921 [rel_patent_id] =>[rel_patent_doc_number] =>)